GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment

GlaxoSmithKline (GSK) plc today announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), for the provision of its inhalation anthrax treatment, raxibacumab.
Source: GSK news - Category: Pharmaceuticals Source Type: news